Glucose-6-phosphatase inhibitors for the treatment of Type 2 diabetes

Bibliography

• HERS HG: Mechanisms of blood glucose homeostasis./ Inher. Metabol Dis. (1990) 13(4):395–410.
   Google Scholar
• GERICH JE: Role of liver and muscle in Type II diabetes. Horm. Metab. Res. Suppl. (1992) 26:18–21.
   PubMedGoogle Scholar
• MOORE MC, CONNOLLY CC, CHERRINGTON AD: Autoregulation of hepatic glucose-production. Eur. J. Endocrinol (1998) 138(3):240–248.
   PubMed Web of Science ®Google Scholar
• CONSOLI A: Role of liver in pathophysiology of NIDDM. Diabetes Care (1992) 15:430–441.
   PubMed Web of Science ®Google Scholar
• •A review describing the role of the liver in glucose homeostasis in Type 2 diabetes.
   Google Scholar
• FERRANNINI E, GROOP LC: Hepatic glucose production in insulin-resistant states. Diabetes Metab. Rev. (1989) 5:711–725.
   PubMedGoogle Scholar
• DEFRONZO RA, BONADONNA RC, FERRANNINI E: Pathogenesis of NIDDM: a balanced overview. Diabetes Care (1992) 15:318–368.
   PubMed Web of Science ®Google Scholar
• •A review of the pathophysiology of Type 2 diabetes.
   Google Scholar
• NORDLIE RC, SUKALSKI KA: Multifunctional glucose-6-phosphatase: a critical review In: The Enzymes of Biological Membranes. Martonosi AN (Ed.) Plenum Press, New York, USA (1985):349–398.
   Google Scholar
• BURCHELL A, WADDELL ID: The molecular basis of the hepatic microsomal glucose-6-phosphatase system. Biochim. Biophys. Acta (1991) 1092:129–137.
   PubMedGoogle Scholar
• MITHIEUX G, VIDAL H, ZITOUN C, et al.: Glucose-6-phosphatase mRNA and activity are increased to the same extent in kidney and liver of diabetic rats. Diabetes (1996) 45:891–896.
   Google Scholar
• NORDLIE RC, FOSTER JD, LANGE AJ: Regulation of glucose production by the liver. Ann. Rev. Nutr. (1999) 19:379–406.
   PubMed Web of Science ®Google Scholar
• ••Gives an excellent review of the role of G-6-Pase in glucose homeostasis.
   Google Scholar
• BURCHELL A: The molecular basis of the type I glycogen storage diseases. Bioassays (1992) 14:395–400.
   PubMed Web of Science ®Google Scholar
• HERS H-G, VAN HOFF F, DE BARSY Glycogen storage disease. In: SCR1VER CR, BEAUDET AI, SLY WS, VALLE D, (Eds.) The metabolic basis ofinherited disease. McGraw-Hill, Inc: London, UK, (1989):425–452
   Google Scholar
• •Gives an overview of the metabolic features in glycogen storage disease.
   Google Scholar
• LIU Z, BARRET EJ, DALKIN AC, ZWART AD, CHOU JY: Effect of acute diabetes on rat hepatic glucose-6-phosphatase activity and its messenger RNA level. Biochem. Biophys. Res. Commun. (1994) 205:680–686.
   PubMed Web of Science ®Google Scholar
• ARGAUD D, ZHANG Q, PAN W, MAITRA S, PILKIS SJ, LANGE A: Regulation of rat liver glucose-6-phosphatase gene expression in different nutritional and hormonal states. Diabetes (1996) 45:1563–1571.
   PubMed Web of Science ®Google Scholar
• BURCHELL A, CAIN DI: Rat hepatic microsomal glucose-6-phosphatase protein levels are increased in streptozotocin-induced diabetes. Diabetologia (1985) 28:852–856.
   PubMed Web of Science ®Google Scholar
• LYALL H, GRANT A, SCOTT HM, BURCHELL A: Regulation of the hepatic microsomal glucose-6-phosphatase enzyme. Biochem. Soc. Trans. (1992) 20:271S.
   Google Scholar
• SEOANE J, TRINH K, ODOHERTY RM, et al.: Metabolic impact of adenovirus-mediated overexpression of the glucose-6-phosphatase catalytic subunit in hepatocytes. J. Biol. Chem. (1997) 272(43):26972–26977.
   Google Scholar
• ••Using adenovirus containing the cDNAencoding the G-6-Pase catalytic subunit to overexpress the catalytic protein, metabolic features resembling that of liver cells from diabetic patients or animals were found.
   Google Scholar
• TRINH KY, O'DOHERTY RM, ANDERSON P, LANGE AJ, NEWGARD CB: Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats. J. Biol Chem. (1998) 273(47):31615–31620.
   PubMed Web of Science ®Google Scholar
• START C, NEWSHOLME EA: The effects of starvation and alloxan-diabetes on the contents of citrate and other metabolic intermediates in rat liver. Biochem. J. (1968) 107(3):411–415.
   PubMed Web of Science ®Google Scholar
• RODEN M, PETERSEN KF, SHULMAN GI: Nuclear magnetic resonance studies of hepatic glucose metabolism in humans. Recent Progress Horm. Res. (2001) 56:219–237.
   PubMedGoogle Scholar
• EFRAT S, TAL M, LODISH HF: The pancreatic beta-cell glucose sensor. Trends Biol. Sci. (1994) 19:535–538.
   PubMed Web of Science ®Google Scholar
• MATSCHINSKY FM: Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes (1996) 45:223–241.
   Google Scholar
• WADDELL ID, BURCHELL A: The microsomal glucose-6-phosphatase enzyme of pancreatic islets. Biochem. J. (1988) 255(2):471–476.
   PubMed Web of Science ®Google Scholar
• ••Gives data on the existence of G-6-Pase inpancreatic n-cells.
   Google Scholar
• KHAN A, CHANDRAMOULI V, OSTENSON CG, et al. Glucose cycling is markedly enhanced in pancreatic islets of obese hyperglycemic mice. Endocrinology (1990) 126(5):2413–2416.
   PubMed Web of Science ®Google Scholar
• KHAN A, CHANDRAMOULI V, OSTENSON CG, LOW H, LANDAU BR, EFENDIC S: Glucose cycling in islets from healthy and diabetic rats. Diabetes (1990) 39(4):456–459.
   PubMed Web of Science ®Google Scholar
• KHAN A, HONG-LIE C, LANDAU BR Glucose-6-phosphatase activity in islets from ob/ob and lean mice and the effect of dexamethasone. Endocrinology (1995) 136(5):1934–1938.
   PubMed Web of Science ®Google Scholar
• •The higher glucose cycling in islets of ob/ob mice and its stimulation by dexamethasone can be attributed to increased G-6-Pase activity.
   Google Scholar
• OSTENSON CG, KHAN A, ABDEL-HALIM SM, et al.: Abnormal insulin secretion and glucose metabolism in pancreatic islets from the spontaneously diabetic GK rat. Diabetologia (1993) 36(1):3–8.
   Google Scholar
• •Insulin secretion stimulated by glucose is markedly impaired in islets from spontaneously diabetic rats.
   Google Scholar
• TRINH K, MINASSIAN C, LANGE AJ, ODOHERTY RM, NEWGARD CB: Adenovirus-mediated expression of the catalytic subunit of glucose-6-phosphatase in ins-I cells - effects on glucose cycling, glucose usage, and insulin-secretion. J. Biol Chem. (1997) 272(40):24837–24842.
   PubMed Web of Science ®Google Scholar
• IIZUKA K, NAKAJIMA H, ONO A, et al.: Stable overexpression of the glucose-6-phosphatase catalytic subunit attenuates glucose sensitivity of insulin secretion from a mouse pancreatic 3-cell line. J. Endocrinol (2000) 164(3):307–314.
   Google Scholar
• KHAN A, LING ZC, PUKK K, HERLING AW, LANDAU BR, EFENDIC S: Effects of 3-mercaptopicolinic acid and a derivative of chlorogenic acid (S-3483) on hepatic and islet glucose-6-phosphatase activity. Eur. J. Pharmacol (1998) 349(2–3):325–33 1.
   Google Scholar
• ARDEN SD, ZAHN T, STEEGERS S et cil.: Molecular cloning of a pancreatic islet-specific glucose-6-phosphatase catalytic subunit-related protein. Diabetes. (1999) 48:531–542.
   Google Scholar
• SUKALSKI KA, NORDLIE RC: Glucose-6-phosphatase: Two concepts of membrane function relationship. In: Advances in Enzymology and related areas of molecular biology. Meister A. (Ed) John Wiley and Sons, New York, USA (1989):93–117.
   Google Scholar
• LI Y, MECHIN M-C, VAN DER WERVE, G: Diabetes affects similarly the catalytic subunit and putative glucose-6-phosphate translocase of glucose-6-phosphatase. J. Biol. Chem. (1999) 274(48):33866–33868.
   PubMed Web of Science ®Google Scholar
• AN J, LI Y, VAN DER WERVE G, NEWGARD CB: Overexpression of the P46 (Ti) translocase component of the glucose-6-phosphatase complex in hepatocytes impairs glycogen accumulation via hydrolysis of glucose 1-phosphate. J. Biol. Chem. (2001) 276(14):10722–10729.
   PubMed Web of Science ®Google Scholar
• ARION WJ, CARLSON PW, WALLIN BK, LANGE AJ: Modification of hydrolytic and synthetic activities of liver microsomal glucose 6-phosphatase. J. Biol. Chem. (1972) 247:2551–1557.
   PubMed Web of Science ®Google Scholar
• ROBBINS BL, FOSTER JD, NORDLIE RC.: Metabolic intermediates as potential regulators of glucose-6-phosphatase. LifC Sciences (1991) 48(10:1075–1082.
   Google Scholar
• WAPNIR RA, STIEL L: Regulation of gluconeogenesis by glycerol and its phosphorylated derivatives. Biochem. Medicine (1985) 33(2):141–148.
   PubMedGoogle Scholar
• BLERIOT Y, SMELT KH, FLEET GWJ et al.: 7-Carbon mimics of D-glucose and L-fucose: activation by 6R-, and inactivation by 6S, 6C-methylglucose of glycogen synthase: inhibition of glucokinase and/or glucose-6-phosphatase. Tetrahedron Lett. (1996) 37(39):7155–7158.
   Web of Science ®Google Scholar
• FOSTER JD, YOUNG SE, NORDLIE RC et al.: Tungstate: a potent inhibitor of multifunctional glucose-6-phosphatase. FASEB J. (1998) 12(8):A1360.
   Web of Science ®Google Scholar
• FOSTER JD, YOUNG SE, NORDLIE RC et al.: Tungstate: a potent inhibitor of multifunctional glucose-6-phosphatase. Arch. Biochem. Biophys. (1998) 354(1):125–132.
   PubMed Web of Science ®Google Scholar
• BARBERA_ A, GOMIS RR; PRATS N, RODRIGUEZ-GIL JE, DOMINGO M, GOMIS R, GUINOVART JJ: Tungstate is an effective antidiabetic agent in Streptozotocin-induced diabetic rats: A long-term study. Diabetologia (2001) 44(4):507–513.
   PubMed Web of Science ®Google Scholar
• WESTERGAARD N, BRAND CL, LEWINSKY, RH et al.: Peroxyvanadium compounds inhibit glucose-6-phosphatase activity and glucagon-stimulated hepatic glucose output in the rat in vivo. Arch. Biochem. Biophys. (1999) 366(1):55–60. Demonstration of the ability of Peroityvanadium compounds to inhibit the G-6-Pase catalytic protein and to abolish glucagon induced increases in blood glucose levels in vivo.
   Google Scholar
• SINGH J, NORDLIE RC, JORGENSON RA: Vanadate: a potent inhibitor of multifunctional glucose-6-phosphatase. Biochem. Biophys. Acta (1981) 678:477–482.
   PubMed Web of Science ®Google Scholar
• MADSEN P, LUNDBECK JM, WESTERGAARD N et al.: Glucose-6-phosphatase catalytic enzyme inhibitors: synthesis and In vitro evaluation of novel 4,5,6-tetrahydrothieno- and - [2,3- c] pyridines. Bioorg-. Med. Chem. (2000) 8:2277–2289.
   PubMed Web of Science ®Google Scholar
• ••Structure-activity relationship of a novelseries of thienopyridine compounds as potent and competitive G-6-Pase catalytic site inhibitors.
   Google Scholar
• WESTERGAARD N, MADSEN P LUNDBAECK JM, JAKOBSEN P, VARMING A, ANDERSEN B: Identification of two novel and potent competitive inhibitors of the glucose-6-phosphatase catalytic protein. Diabetologia (2000) 43\(suppl. 1):A154.
   Google Scholar
• WESTERGAARD N, MADSEN P LUNDBAECK JM, JAKOBSEN P, VARMING A, ANDERSEN B: Identification of two novel and potent competitive inhibitors of the glucose-6-phosphatase catalytic protein. Diabetes Obesity and Metabolism (2001):In press.
   Google Scholar
• ••This paper provides data justifying the G-6-Pase catalytic protein as a potential drug target.
   Google Scholar
• MADSEN P, JAKOBSEN P, WESTERGAARD N: N,N-Dibenzyl-N-benzylidenehydrazines: potent competitive glucose-6-phosphatase catalytic enzyme inhibitors. Bioorg-. Med. Chem. Lett. (2001) 11(16):2165–2167
   PubMed Web of Science ®Google Scholar
• •Structure-activity relationship of a novel series of hydrazone compounds as potent and competitive G-6-Pase catalytic site inhibitors.
   Google Scholar
• MITHIEUX G, BORDETO J-C, MINASSIAN C et al.: Characteristics and specificity of the inhibition of liver glucose-6-phosphatase by arachidonic acid: Lesser inhibitability of the enzyme of diabetic rats. Eur. Biochem. (1993) 213:461–466.
   PubMedGoogle Scholar
• FULCERI R, GAMBERUCCI A, SCOTT HM et al.: Fatty acyl-CoA esters inhibit glucose-6-phosphatase in rat liver microsomes. Biochem. J. (1995) 307:391–397.
   PubMed Web of Science ®Google Scholar
• MITHIEUX G, ZITOUN C: Mechanisms by which fatty-acyl-CoA esters inhibit or activate glucose-6-phosphatase in intact and detergent-treated rat liver microsomes. Eur. J. Biochem. (1996) 235:799–803.
   PubMedGoogle Scholar
• NORDLIE RC, HANSON TL, JOHNS PT: Differential effects of palmitoyl coenzyme-A on liver microsomal inorganic pyrophosphate-glucose phosphotransferase and glucose-6-phosphate phosphohydrolase. J. Biol. Chem. (1967) 242(18):4144–4148.
   PubMed Web of Science ®Google Scholar
• BURCHELL A, BURCHELL B: Stabilization of partially-purified glucose-6-phosphatase by fluoride. FEBS Lett. (1980) 118:180–184.
   PubMed Web of Science ®Google Scholar
• BURCHELL A, BURCHELL B: Identification of a liver microsomal glucose-6-phosphatase. Biochem. J. (1982) 205:567–573.
   PubMed Web of Science ®Google Scholar
• LANGE AJ, ARION WJ, BURCHELL A, BURCHELL B: Aluminum ions are required for stabilization and inhibition of hepatic microsomal glucose-6-phosphatase by sodium fluoride. J. Biol Chem. (1986) 261(1):101–107.
   PubMed Web of Science ®Google Scholar
• BENKOEL L, GULIAN J-M, BONGRAND P et al.: Image analysis for histochemical study of glucose-6-phosphatase inactivation by diethyl pyrocarbonate in normal human liver. J. Histochem Cytochem. (1990) 38(11):1565–1569.
   PubMed Web of Science ®Google Scholar
• BODE AM, FOSTER JD, NORDLIE RC: Inhibition of glucose-6-phosphate phosphohydrolase by 3-mercaptopicolinate and two analogs is metabolically directive. Biochem. Cell Biol. (1993) 71:113–121.
   PubMed Web of Science ®Google Scholar
• FOSTER JD, BODE AM, NORDLIE RC: Time-dependent inhibition of glucose 6-phosphatase by 3-mercaptopicolinic acid. Biochim. Biophys. Acta (1994) 1208:222–228.
   PubMedGoogle Scholar
• MEMOLI KA: A convenient preparation of 3-mercaptopicolinic Acid. Tetrahedron Lett. (1996) 37(21):3617–3618.
   Web of Science ®Google Scholar
• HEMMERLE H, SCHINDLER PW, Burger HJ, HERLING A, BELOW P, SCHUBERT G, RIPPEL R Synthesis and preliminary SAR of new inhibitors of hepatic glucose-6-phosphate translocase. XIIIth International Symposium on Medicinal Chemistry. Paris, France (1994) Abstract P260.
   Google Scholar
• SCHINDLER PW, BELOW P, HEMMERLE H et al.: Identification of two new inhibitors of the hepatic glucose-6-phosphatase system. Drug Dev. Res. (1998) 44:34–40.
   Web of Science ®Google Scholar
• ARION WJ, CANFIELD WK, RAMOS FC et al.: Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase. Arch. Biochem. Biophys. (1997) 339(2):315–322.
   PubMed Web of Science ®Google Scholar
• ARION WJ, CANFIELD WK, SCHINDLER PW et al.: Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase. Diabeto/ogia (1994) 37\(Suppl. 1):A134.
   Google Scholar
• HEMMERLE H, BURGER H-J, BELOW P et al.: Chlorogenic acid and synthetic chlorogenic acid derivatives: novel inhibitors of hepatic glucose-6-phosphate translocase. J. Med. Chem. (1997) 40(2):137–145.
   PubMed Web of Science ®Google Scholar
• ••SAR of a novel series of chlorogenic acid analogues as potent and reversible T,-translocase inhibitors.
   Google Scholar
• ARION WJ, CANFIELD WK, RAMOS FC et al.: Chlorogenic acid analogue S 3483: a potent competitive inhibitor of the hepatic and renal glucose-6-phosphatase systems. Arch. Biochem. Biophys. (1998) 351(2):279–285.
   PubMed Web of Science ®Google Scholar
• HERLING AW, BURGER H-J, SCHWAB D et al.: Pharmacodynamic profile of a novel inhibitor of the hepatic glucose-6-phosphatase system. Diabetes (1998) 47\(suppl. 1):A293.
   Google Scholar
• HERLING AW, BURGER H-J, SCHWAB D et al.: Pharmacodynamic profile of a novel inhibitor of the hepatic glucose-6-phosphatase system. Am. J. PhysioL, Gastrointest. Liver PhysioL (1998) 274(0:G1087–G1093.
   Google Scholar
• ••Data given on the pharmacological profileof the T1-translocase inhibitor S-3483 on blood glucose levels in fed and starved rats in vivo.
   Google Scholar
• SIMON C, HERLIG AW, PREIBISCH G, BURGER H-J: Upregulation of hepatic glucose 6-phosphatase gene expression in rats treated with an inhibitor of glucose-6-phosphate translocase. Arch. Biochem. Biophys. (2000) 373(2):418–428.
   PubMed Web of Science ®Google Scholar
• PARKER JC, VANVOLKENBURG MA, LEVY CB et al.: Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phoisphate translocase. Diabetes (1998) 47: 1630-1636.
   Google Scholar
• ••Data given on the pharmacological profileof the T1-translocase inhibitor S-4048 on blood glucose levels on ob/ob mice in vivo.
   Google Scholar
• HERLING AW, BURGER HJ, SCHUBERT G et al.: Alterations of carbohydrate and lipid intermediary metabolism during inhibition of glucose-6-phosphatase in rats. Eur. J. Pharmacol. (1999) 386:75–82.
   PubMed Web of Science ®Google Scholar
• ARION WJ, CANFIELD WK, CALLAWAY ES et al.: Direct evidence for the involvement of two Glucose 6-phosphate-binding sites in the glucose-6-phosphatase activity of intact liver microsomes. Characterization of T1, the microsomal glucose-6-phosphate transport protein by a direct binding assay. J. Biol. Chem. (1998) 273(10:6223–6227.
   Google Scholar
• KRAMER W, BURGER H-J, ARION WJ et al.: Identification of protein components of the microsomal glucose 6-phosphate transporter by photoaffinity labelling. Biochem. J. (1999) 339:629–638.
   PubMed Web of Science ®Google Scholar
• BURGER H-J, SCHUBERT G, HEMMERLE H et al.: Pharmacological interference with hepatic glucose production. Ann. NY Acad Sci. (1999) 892:312–314.
   PubMed Web of Science ®Google Scholar
• VERTESY L, BURGER H-J, KENJA J et aL: Kodaistatins, novel inhibitors of glucose-6-phosphate translocase Ti from Aspergillus terreus Thom DSM 11247. Isolation and structural elucidation. J. Antibiot. (2000) 53(7):677–686.
   Google Scholar
• BURGER H-J, ARION W, HERLING AW et aL: Kodaistatin A, a new inhibitor from aspergillus terreus of the hepatic glucose-6-phosphatase system. Diabetes (1999) 48\(suppl. 1):A260.
   Google Scholar
• VERTESY L, KURZ M, PAULUS EF et aL: The chemical structure of mumbaistatin, a novel glucose-6-phosphatase translocase inhibitor produced by streptomyces sp DSM 11641.J. Antibiot. (2001) 54(4):354–363.
   Google Scholar
• ••Highly potent novel natural product, whichis an inhibitor of the T, translocase.
   Google Scholar
• ISHII EL, BRACHT A: Glucose release by the liver under conditions of reduced activity of glucose-6-phosphatase. Brazilian J. Med. BioL Res. (1987) 20:837–843.
   PubMed Web of Science ®Google Scholar
• KELMER-BRACHT A, ALVAREZ M, BRACHT A: Effects of stevia rebaudiana natural products on rat liver mitochondria. Biochem. Pharmacy/. (1985) 34(6):873–882.
   PubMed Web of Science ®Google Scholar
• GONZALEZ-MUJICA F, MOTTA N, BECERRA A: Inhibition of hepatic neoglycogenesis and glucose-6-phosphatase by aqueous extract of Bauhinia megalandra leaves. Phytother. Res. (1998) 12:291–293.
   Web of Science ®Google Scholar
• FOSTER JD, PEDERSON BA, NORDLIE RC: Inhibition of the glucose-6-phosphatase system by N-bromoacetylethanolamine phosphate, a potential affinity label for auxiliary proteins. Biochim. Biophys. Acta (1996) 1297:244–254.
   PubMedGoogle Scholar
• FOSTER JD, STEVENS AL, NORDLIE RC: N-bromoacetylethanolamine phosphate as a probe for the identification of a liver microsomal glucose-6-phosphate transporter peptide in rats and ehrlich ascites tumor-bearing mice. Arch. Biochem. Biophys. (2000) 377(1):115–121.
   PubMed Web of Science ®Google Scholar